Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-24

Clinical Trial Update: RedCord in Neurogenic Bowel Dysfunction in Multiple Sclerosis [NA]

View source ↗

Summary

The trial update indicates the RedCord device is being studied for neurogenic bowel dysfunction in people with multiple sclerosis, with recruitment not yet star…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Castilla-La Mancha | Conditions: Multiple Sclerosis, Pelvic Floor Disorder | NA | Status: NOT_YET_RECRUITING